av/ipca--big.svg

COM:IPCA

Ipca Laboratories

  • Stock

Last Close

1,573.55

22/11 09:59

Market Cap

310.50B

Beta: -

Volume Today

295.50K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
7.94B
-
8.87B
11.68%
8.85B
0.22%
8.63B
2.50%
8.81B
2.14%
9.77B
10.79%
11.98B
22.66%
14.59B
21.80%
17.26B
18.33%
18.01B
4.30%
average payables
3.05B
-
3.24B
6.27%
3.67B
13.18%
4.42B
20.60%
4.41B
0.36%
4.74B
7.56%
5.67B
19.66%
6.38B
12.51%
6.12B
4.09%
5.41B
11.53%
average receivables
6.34B
-
6.24B
1.51%
5.57B
10.75%
6.20B
11.37%
7.74B
24.81%
8.89B
14.80%
10.23B
15.07%
10.98B
7.38%
11.60B
5.63%
11.15B
3.92%
book value per share
77.64
-
87.50
12.69%
90.48
3.41%
97.28
7.51%
106.52
9.50%
123.58
16.02%
143.58
16.18%
185.63
29.29%
216.47
16.61%
230.30
6.39%
capex per share
-15.55
-
-22.12
42.28%
-9.80
55.70%
-5.40
44.88%
-5.42
0.29%
-7.15
31.91%
-12.12
69.65%
-14.27
17.75%
-18.88
32.25%
-19.49
3.25%
capex to depreciation
-3.80
-
-3.11
18.28%
-1.44
53.81%
-0.79
45.12%
-0.77
2.40%
-0.99
28.65%
-1.46
47.02%
-1.73
18.80%
-2.06
19.22%
-1.89
8.26%
capex to operating cash flow
-0.73
-
-1.23
67.07%
-0.50
58.96%
-0.49
1.99%
-0.40
18.73%
-0.37
8.50%
-0.54
48.00%
-0.33
38.90%
-0.56
68.70%
-0.61
9.68%
capex to revenue
-0.12
-
-0.18
48.24%
-0.09
51.48%
-0.04
50.20%
-0.04
1.50%
-0.05
14.68%
-0.07
37.40%
-0.07
0.76%
-0.08
22.70%
-0.08
4.66%
cash per share
2.96
-
4.11
38.85%
6.91
68.11%
5.86
15.09%
8.66
47.73%
14.71
69.78%
16.54
12.46%
29.91
80.87%
53.55
79.03%
89.68
67.46%
days of inventory on hand
261.08
-
279.52
7.06%
277.50
0.72%
276.61
0.32%
273.26
1.21%
303.37
11.02%
282.61
6.84%
323.08
14.32%
322.02
0.33%
275.88
14.33%
days payables outstanding
105.13
-
92.49
12.02%
140.33
51.72%
143.50
2.26%
131.41
8.42%
148.31
12.86%
130.26
12.17%
134.95
3.60%
96.66
28.38%
83.09
14.04%
days sales outstanding
75.56
-
67.49
10.68%
69.01
2.26%
81.47
18.05%
96.29
18.19%
92.15
4.30%
89.17
3.22%
74.02
16.99%
78.33
5.82%
58.00
25.95%
debt to assets
0.19
-
0.25
30.66%
0.21
14.41%
0.18
13.88%
0.15
15.68%
0.10
32.97%
0.10
6.83%
0.04
54.06%
0.11
141.63%
0.17
62.49%
debt to equity
0.31
-
0.42
37.69%
0.35
16.94%
0.29
17.10%
0.23
19.93%
0.15
36.21%
0.14
7.30%
0.06
59.11%
0.15
160.40%
0.25
72.50%
dividend yield
0.01
-
0.00
25.95%
0.00
54.53%
0.00
98.54%
0.00
5,887.88%
0.00
31.30%
0.01
451.61%
0.00
39.12%
0.00
10.90%
0.00
31.57%
earnings yield
0.04
-
0.03
27.99%
0.01
59.23%
0.03
95.64%
0.03
10.74%
0.04
26.90%
0.03
4.77%
0.05
37.16%
0.03
30.85%
0.02
29.88%
enterprise value
111.90B
-
88.56B
20.86%
79.75B
9.94%
85.59B
7.32%
88.71B
3.64%
124.72B
40.59%
180.30B
44.56%
242.08B
34.27%
275.71B
13.89%
207.80B
24.63%
enterprise value over ebitda
14.84
-
15.64
5.37%
25.56
63.40%
18.42
27.91%
18.19
1.27%
16.82
7.54%
18.38
9.30%
15.05
18.13%
20.10
33.56%
19.75
1.77%
ev to operating cash flow
20.93
-
19.45
7.08%
16.23
16.58%
30.96
90.83%
26.01
16.02%
25.34
2.57%
31.95
26.12%
22.21
30.50%
32.21
45.03%
25.79
19.93%
ev to sales
3.45
-
2.84
17.55%
2.80
1.35%
2.72
3.04%
2.77
1.79%
3.38
22.10%
3.96
17.08%
4.53
14.60%
4.78
5.48%
3.33
30.40%
free cash flow per share
5.63
-
-4.08
172.46%
9.67
337.00%
5.55
42.63%
8.10
45.91%
12.34
52.36%
10.21
17.24%
28.77
181.71%
14.86
48.33%
12.27
17.43%
free cash flow yield
0.01
-
-0.01
196.28%
0.03
358.86%
0.02
46.46%
0.02
36.87%
0.03
4.17%
0.01
42.18%
0.03
106.02%
0.01
53.85%
0.02
8.60%
graham net net
-9.83
-
-23.96
143.80%
-21.49
10.30%
-15.37
28.49%
-5.36
65.10%
7.68
243.26%
11.72
52.46%
40.08
242.12%
45.16
12.66%
46.50
2.98%
graham number
181.93
-
142.17
21.85%
88.33
37.87%
132.61
50.13%
150.78
13.70%
221.26
46.74%
278.43
25.84%
433.58
55.72%
411.97
4.98%
310.28
24.68%
income quality
0.85
-
1.26
48.73%
4.26
238.09%
1.02
76.01%
1.17
14.83%
0.90
23.28%
0.76
15.23%
0.79
3.34%
0.75
4.49%
1.08
43.44%
intangibles to total assets
0.02
-
0.03
39.34%
0.04
10.78%
0.03
32.91%
0.03
22.60%
0.05
55.33%
0.04
23.28%
0.03
29.88%
0.03
9.35%
0.02
21.10%
interest coverage
33.07
-
15.75
52.38%
6.98
55.67%
12.60
80.56%
12.10
3.97%
29.24
141.56%
48.63
66.34%
162.53
234.19%
157.35
3.19%
17.37
88.96%
interest debt per share
24.73
-
37.97
53.56%
32.83
13.55%
29.19
11.08%
25.79
11.65%
19.13
25.84%
20.45
6.89%
10.82
47.09%
32.10
196.75%
60.19
87.49%
inventory turnover
1.40
-
1.31
6.60%
1.32
0.73%
1.32
0.32%
1.34
1.23%
1.20
9.92%
1.29
7.35%
1.13
12.52%
1.13
0.33%
1.32
16.72%
invested capital
0.31
-
0.42
37.69%
0.35
16.94%
0.29
17.10%
0.23
19.93%
0.15
36.21%
0.14
7.30%
0.06
59.11%
0.15
160.40%
0.25
72.50%
market cap
106.62B
-
80.24B
24.74%
73.47B
8.45%
78.73B
7.16%
83.93B
6.60%
122.88B
46.41%
175.88B
43.13%
241.09B
37.08%
270.39B
12.15%
205.56B
23.97%
net current asset value
3.52B
-
100.50M
97.14%
155.60M
54.83%
2.30B
1,376.48%
5.17B
124.93%
9.65B
86.75%
12.37B
28.18%
20.85B
68.54%
23.87B
14.50%
24.78B
3.81%
net debt to ebitda
0.70
-
1.47
109.51%
2.01
37.23%
1.48
26.69%
0.98
33.61%
0.25
74.73%
0.45
81.96%
0.06
86.29%
0.39
527.56%
0.21
45.27%
net income per share
18.95
-
10.27
45.81%
3.83
62.67%
8.03
109.66%
9.49
18.06%
17.61
85.61%
24.00
36.30%
45.01
87.56%
34.85
22.58%
18.58
46.68%
operating cash flow per share
21.18
-
18.04
14.83%
19.47
7.96%
10.95
43.76%
13.52
23.41%
19.48
44.16%
22.33
14.62%
43.04
92.72%
33.74
21.61%
31.77
5.86%
payables turnover
3.47
-
3.95
13.67%
2.60
34.09%
2.54
2.21%
2.78
9.20%
2.46
11.39%
2.80
13.86%
2.70
3.48%
3.78
39.62%
4.39
16.33%
receivables turnover
4.83
-
5.41
11.95%
5.29
2.21%
4.48
15.29%
3.79
15.39%
3.96
4.49%
4.09
3.33%
4.93
20.47%
4.66
5.50%
6.29
35.05%
research and ddevelopement to revenue
0.02
-
0.01
32.86%
0.01
10.08%
0.01
6.93%
0.01
37.27%
0.01
32.34%
0.01
22.54%
0.01
42.47%
0.01
26.09%
0.01
1.91%
return on tangible assets
0.15
-
0.07
53.90%
0.03
62.66%
0.05
99.94%
0.06
14.22%
0.10
71.20%
0.12
16.52%
0.19
61.08%
0.12
38.24%
0.06
53.09%
revenue per share
128.65
-
123.48
4.02%
112.73
8.70%
124.78
10.69%
127.04
1.82%
146.14
15.03%
180.43
23.47%
210.87
16.87%
227.29
7.79%
246.16
8.30%
roe
0.24
-
0.12
51.91%
0.04
63.91%
0.08
95.02%
0.09
7.81%
0.14
59.98%
0.17
17.32%
0.24
45.06%
0.16
33.61%
0.08
49.88%
roic
0.21
-
0.08
60.12%
0.05
42.65%
0.06
29.88%
0.07
12.16%
0.12
71.27%
0.15
25.71%
0.23
52.99%
0.14
37.67%
0.07
50.90%
sales general and administrative to revenue
0.01
-
0.02
29.20%
0.02
10.08%
0.02
7.10%
0.03
37.22%
0.02
14.09%
0.01
40.65%
0.02
41.44%
0.01
29.73%
0.01
4.47%
shareholders equity per share
77.64
-
87.50
12.69%
90.48
3.41%
97.28
7.51%
106.52
9.50%
123.58
16.02%
143.58
16.18%
185.63
29.29%
216.47
16.61%
230.30
6.39%
stock based compensation to revenue
0.00
-
0.00
97.29%
tangible asset value
18.79B
-
20.76B
10.44%
21.36B
2.92%
23.53B
10.14%
25.58B
8.72%
29.14B
13.91%
34.42B
18.14%
45.55B
32.33%
53.47B
17.39%
57.18B
6.93%
tangible book value per share
74.46
-
82.24
10.44%
84.64
2.92%
93.22
10.14%
101.35
8.72%
115.33
13.79%
136.25
18.14%
179.86
32.01%
210.77
17.19%
225.41
6.95%
working capital
8.09B
-
7.10B
12.29%
6.98B
1.67%
7.78B
11.51%
9.38B
20.54%
12.80B
36.50%
15.29B
19.45%
23.04B
50.65%
29.91B
29.84%
33.83B
13.11%

All numbers in (except ratios and percentages)